Psychopharmacological enhancement: a conceptual framework.

Area of Science:

• Philosophy of Medicine and Psychiatry
• Neuroscience
• Ethics

Background:

• The advent of novel psychotropic agents introduces the potential for their use in cognitive and emotional enhancement (e.g., 'smart pills', 'happy pills').
• This raises fundamental philosophical questions regarding the definition of 'disorder', the nature of psychiatric illness, and the ethics of psychotropic use.

Purpose of the Study:

• To propose a naturalistic conceptual framework for analyzing the complex issues surrounding psychotropic enhancement.
• To explore the philosophical underpinnings of the debate, including the contrasting views of pharmacological Calvinism and psychotropic utopianism.

Main Methods:

• Contrasting classical and critical conceptualizations of medical and psychiatric categories.
• Developing an integrative position grounded in cognitive-affective research.
• Analyzing the metaphors of 'disorder' used in the pharmacological Calvinism versus psychotropic utopianism debate.

Main Results:

• A naturalistic framework is presented to address the philosophical and ethical dimensions of psychotropic use for enhancement.
• The framework distinguishes between the justification for treating serious psychiatric disorders and the use of psychotropics for sub-threshold phenomena.

Conclusions:

• Psychiatric treatment of severe mental disorders using psychotropic interventions is deemed justifiable.
• The application of psychotropic agents for sub-threshold conditions necessitates a careful evaluation of available evidence and ethical values, given often limited data.